References in periodicals archive ?
Rapid and short-acting insulin: Insulin lispro (Humalog), asparte (Novorapid), and glulisine (Apidra) are all analogue insulin--they have an altered molecular structure that allows rapid absorption following subcutaneous injection.
Rapid-acting analogues (aspart, glulisine, lispro) have a shorter duration of action, quicker onset and less variability.
Summary: Sanofi-aventis announced yesterday that the European Commission has approved APIDRAA (insulin glulisine [rDNA origin] injection), a rapid-acting insulin analog for the control of hyperglycemia in adolescents and children (6 years and older) with diabetes.
The approval of Apidra (insulin glulisine [rDNA origin] injection) for paediatric use provides children (6 years and older) with the option of using Apidra as part of their overall diabetes treatment plan, usually in combination with a basal insulin, it said.
Treatments that predominantly address postprandial coverage (or bolus treatments) include insulin secretagogues, regular human insulin, exenatide, pramlintide, and the rapid-acting insulin analogs: insulin lispro (Humalog), insulin aspart (Novolog), and insulin glulisine (Apidra).
Tenders are invited for Supply of Rapid Acting Insulin Analogue Like Insulin Aspart Or Insulin Glulisine Or Insulin Lispro Cartridge 100 Iu Per Ml , 3 Ml Cartridges With Complementary Pen Free Pen Per Patient
Comparison of 3 intensified insulin regimens added to oral therapy for type 2 diabetes: twice-daily aspart premixed vs glargine plus 1 prandial glulisine or stepwise addition of glulisine to glargine" [ABSTRACT 3515]
Glulisine is approved for use in insulin pumps, but has not been studied in women during pregnancy.
A third insulin analog on the market, insulin glulisine (Apidra), approved in 2004, has a pharmacokinetic profile that is similar to insulin aspart and lispro, but Mr.
Before insulin analogs (aspart, lispro, glulisine, glargine, and detemir) were available, conventional human insulins were the mainstay of therapy for T1DM.
Tenders are invited for Premix Insulin Aspart Or Glulisine Or Lispro 30:70 Or 25:75 Inj 100 Iu Per Ml 3Ml Cartridge With Complimentary Pen , In The Ratio Of 5 Cartridge To One Pen
DQoL improved significantly for all groups at all wks; average improvement was greater for basal Lantus (insulin glargine) + 1 prandial Apidra (insulin glulisine) dose (GLARG+1) and stepwise addition of prandial glulisine (GLARG+0-3) vs premix (P≤0.